MetLife earnings: what to watch
The next MetLife results are expected on November 4, 2026. Watch whether adjusted earnings growth and expense control continue after the PineBridge addition.
What has MetLife guided for the year?
Management’s promise is a set of operating gauges, not a promise of one GAAP profit number. GAAP is the standard accounting rulebook; adjusted earnings remove items MetLife considers unusually volatile or less useful for judging ongoing operations, such as investment gains, derivative effects and certain acquisition costs. Adjusted return on equity, or ROE, measures adjusted profit against shareholder capital, while the direct expense ratio compares direct costs with the revenue base.
| The period it covers | Low | High | The date it was given | |
|---|---|---|---|---|
| Adjusted return on equity, excluding total notable items | 2026–2028 (near term) | 15.0% | 17.0% | 2026-08-05 |
| Double-digit adjusted EPS growth | 2026–2028 (near term) | 2026-02-04 | ||
| Free cash flow ratio | Two-year average; near term | 65.0% | 75.0% | 2026-02-04 |
| Direct expense ratio target | 2026 | 12.1% | 12.1% | 2026-08-05 |
| Variable investment income | 2026 | 1,600 | 1,600 | 2026-08-05 |
| Corporate & Other adjusted loss | 2026 | 500 | 700 | 2026-02-04 |
What this means. “Double-digit adjusted earnings per share growth” means growth of at least 10 percent, but the company does not say the exact expected rate.
Has MetLife kept its past promises?
MetLife also reports an encouraging first year under New Frontier. In 2025, adjusted earnings per share grew by double digits, adjusted ROE reached 16%, and the direct expense ratio was 11.7%, within or better than the stated targets. The company also says it exceeded every commitment in its previous strategy.
What do MetLife’s last eight quarters show?
MetLife reported adjusted-earnings growth across its operating segments, supported by favorable underwriting and volume growth. Adjusted premiums, fees and other revenues excluding PRT also grew. That breadth matters because improvement in one product can be temporary, while progress across several businesses is more informative.
Reported investment income rose 18% in Q2 2026. Adjusted investment income rose 7%, because fair-value movements affected the reported figure. MetLife also recorded an impairment related to a planned Ukraine disposal and real-estate impairments during the first half. Those charges do not erase operating progress, but they make reported net income a poor figure to annualize.
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|---|---|
| Core earnings (company's measure) | 1,573 | 1,586 | 1,648 | 1,584 | 1,362 | 1,349 | 1,459 | 1,375 |
| Net income | 736 | 1,185 | 809 | 896 | 729 | 945 | 1,271 | 1,342 |
| EPS, diluted | 1.09 | 1.74 | 1.17 | 1.22 | 1.03 | 1.28 | 1.78 | 1.81 |
| Calculation input: Adjusted earnings available to common shareholders per diluted common share | 2.43 | 2.42 | 2.49 | 2.37 | 2.02 | 1.96 | 2.09 | 1.95 |
What should I watch in MetLife’s next results?
MetLife’s scheduled November 5 results call will test whether adjusted earnings growth and expense control continue after the PineBridge addition. A beat alone will not settle the question; the mix of underwriting, investments, taxes and share count matters.